LPC

Lion Point Capital Portfolio holdings

AUM $19.3M
1-Year Est. Return 110.67%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+110.67%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$19.3M
AUM Growth
+$1.72M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
42
New
Increased
Reduced
Closed

Top Buys

1
+$1.35M
2
+$601K
3
+$590K
4
QURE icon
uniQure
QURE
+$567K
5
JANX icon
Janux Therapeutics
JANX
+$447K

Top Sells

1
+$1.14M
2
+$912K
3
+$909K
4
INSM icon
Insmed
INSM
+$900K
5
ARQT icon
Arcutis Biotherapeutics
ARQT
+$769K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MIST icon
1
Milestone Pharmaceuticals
MIST
$147M
$1.53M 7.89%
755,000
+96,447
PRAX icon
2
Praxis Precision Medicines
PRAX
$9.17B
$1.31M 6.79%
4,450
-1,250
MLTX icon
3
MoonLake Immunotherapeutics
MLTX
$1.25B
$890K 4.6%
67,500
FENC icon
4
Fennec Pharmaceuticals
FENC
$281M
$866K 4.48%
112,434
-10,566
JSPR icon
5
Jasper Therapeutics
JSPR
$37.8M
$851K 4.4%
465,000
+66,442
BNTC icon
6
Benitec Biopharma
BNTC
$371M
$835K 4.32%
62,000
RPRX icon
7
Royalty Pharma
RPRX
$20.3B
$827K 4.28%
21,400
GERN icon
8
Geron
GERN
$989M
$763K 3.95%
578,000
+78,000
SNDX icon
9
Syndax Pharmaceuticals
SNDX
$1.92B
$756K 3.91%
36,000
-19,000
ARDX icon
10
Ardelyx
ARDX
$1.57B
$750K 3.88%
128,650
-34,100
CUE icon
11
Cue Biopharma
CUE
$25.8M
$673K 3.48%
+2,202,854
IRON icon
12
Disc Medicine
IRON
$2.51B
$643K 3.33%
8,100
-2,500
SRPT icon
13
Sarepta Therapeutics
SRPT
$1.71B
$613K 3.17%
+28,500
BHVN icon
14
Biohaven
BHVN
$1.57B
$584K 3.02%
51,700
+29,000
HUMA icon
15
Humacyte
HUMA
$216M
$480K 2.49%
500,000
+416,500
KURA icon
16
Kura Oncology
KURA
$755M
$478K 2.47%
46,000
MCRB icon
17
Seres Therapeutics
MCRB
$81.1M
$470K 2.43%
31,570
+4,432
CMPS
18
Compass Pathways
CMPS
$797M
$400K 2.07%
58,000
DAWN icon
19
Day One Biopharmaceuticals
DAWN
$1.06B
$391K 2.03%
42,000
RGNX icon
20
Regenxbio
RGNX
$468M
$383K 1.98%
26,600
-31,150
BBIO icon
21
BridgeBio Pharma
BBIO
$12.7B
$382K 1.98%
5,000
-8,300
MLYS icon
22
Mineralys Therapeutics
MLYS
$2.32B
$381K 1.97%
10,500
-28,500
VTYX icon
23
Ventyx Biosciences
VTYX
$1B
$375K 1.94%
+41,500
LNTH icon
24
Lantheus
LNTH
$5.06B
$366K 1.89%
+5,500
DYN icon
25
Dyne Therapeutics
DYN
$2.66B
$352K 1.82%
+18,000
1
2